European Healthcare AI | NVIDIA Innovation
- European healthcare and life sciences companies are demonstrating AI-driven solutions to address critical challenges like staffing shortages, aging populations and rising costs.
- Startups participating in the NVIDIA Inception program are developing solutions across biopharma, population health and digital medicine.
- Companies are leveraging the NVIDIA Bionemo platform,NVIDIA DGX Cloud and the NVIDIA Cloud Partner network to improve health outcomes.
European healthcare is undergoing a profound transformation, driven by innovative AI solutions showcased at NVIDIA GTC Paris. This industry is using AI to tackle critical challenges like staffing shortages and rising costs, with startups developing solutions across biopharma and digital medicine. The NVIDIA Inception programme is providing vital resources, including tools and venture capital exposure. Leading companies are leveraging NVIDIA platforms to revolutionize health outcomes. Basecamp Research is building an AI-ready genomics database, while AI agents are transforming healthcare delivery in the UK. Pangaea Data is closing care gaps with its AI platform. This progress is supported by venture capital firms like Sofinnova. News Directory 3 highlights this shift. Are you ready to discover what will shape the future of health?
NVIDIA GTC Paris: AI Advances Healthcare in Europe
Table of Contents
European healthcare and life sciences companies are demonstrating AI-driven solutions to address critical challenges like staffing shortages, aging populations and rising costs. The innovations were on display at NVIDIA GTC Paris.
Startups participating in the NVIDIA Inception program are developing solutions across biopharma, population health and digital medicine. the program provides access to tools,training and venture capital exposure.
Companies are leveraging the NVIDIA Bionemo platform,NVIDIA DGX Cloud and the NVIDIA Cloud Partner network to improve health outcomes.
Basecamp Research Builds AI-Ready Genomics Database
Basecamp Research, a London-based startup, has launched BaseData, a biological dataset for generative AI in life sciences. The database contains over 9.8 billion new biological sequences and over a million previously unknown species, collected from 125 locations in 26 countries.
BaseData is being used to train next-generation foundation models using the NVIDIA BioNeMo Framework on the Nvidia DGX Cloud platform.
“Data-optimal scaling is the key to overcoming the real-world limitations of current biological models,” said Phil Lorenz, chief technology officer at Basecamp Research. “Combined with NVIDIA’s compute and AI stack, we’re training models that can understand and generate biology like never before.”
AI Agents Transform Healthcare Delivery in the UK
Guy’s and St. Thomas’ NHS Foundation Trust is launching the proactive and accessible Conversion of Healthcare (PATH) initiative in collaboration with General Catalyst and startups Hippocratic AI and Sword health. The goal is to integrate AI agents to reduce waitlists, improve pain management and streamline triage.
Hippocratic AI’s conversational agents automate tasks like patient outreach and referral validation. sword Health’s AI Care platform has delivered 6.5 million AI sessions to over 500,000 patients.
“PATH aims to deliver better, faster and fairer healthcare for all,” said Ian Abbs, CEO of Guy’s and St. Thomas’. “By combining cutting-edge technology,including AI,with clinical care,we can build a more proactive NHS.”
Pangaea Data Closes Care Gaps with AI Platform
Pangaea Data, based in London and San Francisco, is helping identify under-treated patients using its AI platform, which is powered by the NVIDIA NeMo Agent toolkit. The platform also uses Nvidia NIM microservices to identify patients with hard-to-diagnose diseases.
“The NeMo Agent toolkit and NVIDIA NIM microservices enable us to reduce the time taken to configure our platform for each disease condition from weeks to a single day, helping accelerate our mission of improving patient outcomes globally,” said Vibhor Gupta, founder and CEO of Pangaea Data.
Pangaea’s platform is being deployed across health systems in the U.S., U.K., spain and Barbados.
Sofinnova and Cure51 Tap NVIDIA DGX Cloud
European venture capital firms like Sofinnova are supporting AI startups through Nvidia DGX Cloud. Selected VCs can offer portfolio companies early access to DGX Cloud,including access to 25 NVIDIA H100 GPU nodes for three months.
Cure51, a Sofinnova portfolio company, achieved a 17x speedup in genomic analysis and 2x cost savings by shifting workloads to NVIDIA Parabricks running on DGX Cloud.
Sensible Biotechnologies reduced its optimization cycles for cell-based mRNA therapeutics design from 15 days to just one using NVIDIA’s sovereign AI infrastructure.
What’s next
The showcased advancements at NVIDIA GTC Paris signal a continued push toward AI-driven healthcare solutions in Europe. As these technologies mature and become more widely adopted, they promise to reshape patient care, accelerate drug discovery and improve overall health outcomes.